Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Integrated Biopharma Inc (OP: INBP )

0.3384 +0.0131 (+4.03%)
Streaming Delayed Price Updated: 12:35 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Integrated Biopharma Inc

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
Via ACCESSWIRE
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022
Via ACCESSWIRE
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022
Via ACCESSWIRE
Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President
Via ACCESSWIRE
Integrated BioPharma Announces Change in Directors
HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's... 
From Integrated BioPharma, Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022
HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the... 
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021
HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the... 
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021
HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for the... 
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021
HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021.... 
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2021. Revenue for the... 
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Integrated BioPharma Announces Launch of Investors Website
Integrated BioPharma Announces Launch of Investors Website HILLSIDE, NJ / ACCESSWIRE / April 8, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announces the launch of an... 
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.